Intelligent Bio Solutions Inc. (INBS)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$2.41
-1.88%
Mkt Cap $2.65M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $5.50M | $896.77K | -83.70% | $0.40 | -$2.82 | -805.00% | — | — |
| Q4 2025 Nov 12, 2025 | $4.80M | $1.11M | -76.84% | -$1.50 | -$3.50 | -133.33% | — | — |
| Q3 2025 Aug 15, 2025 | $4.30M | $843.88K | -80.37% | -$1.20 | -$0.37 | +69.17% | — | — |
| Q2 2025 May 13, 2025 | $3.30M | $728.87K | -77.91% | -$2.80 | -$0.44 | +84.29% | — | — |
| Q1 2025 Feb 13, 2025 | $2.30M | $607.49K | -73.59% | -$3.20 | -$0.50 | +84.38% | — | — |
| Q4 2024 Nov 7, 2024 | $1.80M | $872.29K | -51.54% | -$0.53 | -$0.70 | -32.08% | — | — |
| Q3 2024 Sep 19, 2024 | $1.40M | $727.82K | -48.01% | -$0.51 | -$1.34 | -162.75% | — | — |
| Q2 2024 May 8, 2024 | $1.20M | $823.80K | -31.35% | -$0.87 | -$1.43 | -64.37% | — | — |
| Q1 2024 Feb 9, 2024 | $1.00M | $764.06K | -23.59% | -$3.24 | -$2.07 | +36.11% | — | — |
| Q4 2023 Nov 8, 2023 | $1.00M | $796.09K | -20.39% | -$7.68 | -$12.48 | -62.50% | — | — |
| Q3 2023 Aug 24, 2023 | $595.50K | $443.13K | -25.59% | -$19.93 | -$22.93 | -15.05% | — | — |
| Q2 2023 May 11, 2023 | $420.00K | $457.06K | +8.82% | -$2.07 | -$24.37 | -1077.29% | — | — |
| Q1 2023 Feb 14, 2023 | $700.00K | $356.68K | -49.05% | -$2.20 | -$0.46 | +79.09% | — | — |
| Q4 2022 Nov 9, 2022 | — | $311.32K | — | -$24.00 | -$16.23 | +32.38% | — | — |
| Q2 2022 May 10, 2022 | — | $192.50K | — | -$3.20 | -$1.80 | +43.75% | — | — |
| Q1 2022 Feb 10, 2022 | $300.00K | $177.79K | -40.74% | -$3.20 | -$4.60 | -43.75% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | — | -$20.46 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $1.61M | — | — | -$12.56 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $34.29K | — | — | -$53.03 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$27.61 | — | — | — |